Поисковый запрос: (<.>A=Yasuda, Satoshi$<.>) |
Общее количество найденных документов : 29
Показаны документы с 1 по 20
|
|
1.
| Yasuda Severe diastolic dysfunction with preserved energy conversion efficiency after countershock // Amer. J. Physiol.: Heart and Circ. Physiol., 1997. Vol. 42, N 2.-С.H583-H592
|
2.
| Yasuda Severe diastolic dysfunction with preserved energy conversion efficiency after countershock // Amer. J. Physiol.: Heart and Circ. Physiol., 1997. Vol. 42, N 2.-С.H583-H592
|
3.
| Yasuda Severe diastolic dynsfunction with preserved energy conversion efficiency after countershock // Amer. J. Physiol., 1997. Vol. 273, N 2.-С.H583-H592
|
4.
| Yasuda Severe diastolic dynsfunction with preserved energy conversion efficiency after countershock // Amer. J. Physiol., 1997. Vol. 273, N 2.-С.H583-H592
|
5.
| Yasuda Endothelin-1 ameliorates contractile depression by lipopolysaccharide in cardiac myocytes // Amer. J. Physiol.: Heart and Circ. Physiol., 1997. Vol. 42, N 3.-С.1403-1407
|
6.
| Yasuda Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes // Amer. J. Physiol., 1999. Vol. 276, N 5.-С.H1442-H1449
|
7.
| Yasuda Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes // Amer. J. Physiol., 1999. Vol. 276, N 5.-С.H1442-H1449
|
8.
| Terminally alkylated heparin 2: Potent antiproliferative agent for vascular smooth muscle cells // Biomacromolecules, 2001. Vol. 2, N 4.-С.1178-1183
|
9.
| Terminally alkylated heparin 2: Potent antiproliferative agent for vascular smooth muscle cells // Biomacromolecules, 2001. Vol. 2, N 4.-С.1178-1183
|
10.
| Terminally alkylated heparin 2: Potent antiproliferative agent for vascular smooth muscle cells // Biomacromolecules, 2001. Vol. 2, N 4.-С.1178-1183
|
11.
| Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis // Circ. J., 2003. Vol. 67, N 10.-С.898-900
|
12.
| Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis // Circ. J., 2003. Vol. 67, N 10.-С.898-900
|
13.
| In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice // J. Vasc. Res., 2008. Vol. 45, N 2.-С.123-128
|
14.
| In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice // J. Vasc. Res., 2008. Vol. 45, N 2.-С.123-128
|
15.
| Impact of coronary artery remodeling on mosinterpretation of angiographic disease eccentricity: Evidence from intravascular ultrasound // Int. J. Cardiol., 1999. Vol. 70, N 3.-С.275-282
|
16.
| Impact of coronary artery remodeling on mosinterpretation of angiographic disease eccentricity: Evidence from intravascular ultrasound // Int. J. Cardiol., 1999. Vol. 70, N 3.-С.275-282
|
17.
| HVEM expression contributes to tumor progression and prognosis in human colorectal cancer // Anticancer Res., 2015. Vol. 35, N 3.-С.1361-1367
|
18.
| HVEM expression contributes to tumor progression and prognosis in human colorectal cancer // Anticancer Res., 2015. Vol. 35, N 3.-С.1361-1367
|
19.
| Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction // Clin. Sci., 2007. Vol. 112, N 1.-С.43-49
|
20.
| Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction // Clin. Sci., 2007. Vol. 112, N 1.-С.43-49
|
&uf('+1W2226#',v2226), ?>
|
|